Calcific Aortic Valve Stenosis
📧 Sign up to get email alerts when something new happens for Calcific Aortic Valve Stenosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis [Phase 2]
A multicenter Phase 2 trial is evaluating whether lowering lipoprotein(a) with Pelacarsen (TQJ230) can influence the progression of calcific…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study [Phase 2, Phase 3]
A randomized, placebo-controlled Phase 2/3 trial evaluating ataciguat to slow progression of moderate calcific aortic valve stenosis is curr…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Potential Role of Sirtuins As Epigenetic Biomarkers of the Patient with Atherosclerosis or Calcific Aortic Stenosis
This clinical trial investigates whether sirtuin proteins can serve as epigenetic biomarkers in patients with atherosclerosis or calcific ao…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Cerebral Protection in Transcatheter Aortic Valve Replacement [NA]
This clinical trial update reports results for cerebral protection during transcatheter aortic valve replacement in patients with severe sym…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Safety of Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis [Phase 1]
Phase 1 safety trial update evaluating ataciguat in patients with moderate calcific aortic valve stenosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.